PS: With the 'very rigorously pre-selected group' I was referring to the actual patients taking part in the intramural. Whether it's 25, 40 or 50%, and depending on context, it's certainly a high rate of misdiagnosis.
There was no rate of misdiagnosis in the 17 people that took part. They did not have any alternative diagnoses, they were selected on the basis of having ME/CFS (which is defined by the presence of certain symptoms) and ruling out alternative diagnoses. It's certainly possible that someone still has a condition that is missed as part of that whole process but for obvious reasons we have no numbers for that and of course these were more rigorously selected patients than we've seen elsewhere and it would seem that chances are if something is missed then those people will have been less likely to recover, rather than the opposite, because no treatment was reported for those people.It’s no surprise that none of this works with only 17 people (25% with other diagnoses like cancer and 25% recovered? Are these the right numbers?).
I've said it before, but I think it is worth mentioning again: Something that could be a possible quick "S4ME project" is request data from the NIH to decipher which of the people later recovered (25% of the group) to see if these people differed in any way from the cohort in their biological measurements. This will introduce issues surrounding p-hacking and the sample size will diminish once more and since the study didn't yield any leads the whole project probably isn't worth much, but it should be fairly straightforward. Moreover, people in the intramural study have gone on to be part of further studies (for example the WASF3 study), so it might be worth a look.
Yes and we'd also like to speak of ME/CFS knowing what the biology entails but we have no idea about that because there have been no biological findings that have been positive. The only thing we have are negative results. Including brain autopsys and neuroimaging studies.Technically speaking, if you want to speak of actual ME/CFS recovery, it would be good to know what exactly they recovered from biologically first.
From my understanding, in that case it then becomes a discussion of "there is something that causes symptoms that appear to be identical to ME/CFS, that goes on for many years, but that can be recovered from" which again gives the presence of recovery value in trying to understand the then existing differing illnesses. As I see it the high recovery rate (25%) in the intramural study can be explained by 3 things: Rigorous workout to rule out other conditions that would otherwise go untreated (for example seen as part of the study: cancer, Parkinson, Atypical myositis, Primary biliary cholangitis had all been missed previously), low sample sizes inflating effects, short term illness giving higher chances of recovery (which is what we've seen in other studies and in the study patients had been sick for shorter than 5 years).If I had to bet, I would bet the people who recovered did not have what I have, but I can't know for sure. The long-term data clearly show the vast majority of people don't recover, that alone should invite some serious thoughts about recovery in a syndrome space.